1. Centers for Disease Control and Prevention. Tobacco product use among US middle and high school students—National Youth Tobacco Survey, 2023. MMWR. 2023;72(44):1173-1182.

2. U.S. Department of Health and Human Services. Smoking Cessation: A Report of the Surgeon General. Washington, DC: Office of the Surgeon General; 2020.

3. Centers for Disease Control and Prevention. Adult Data on Smoking. Available at https://www.cdc.gov/tobacco/data_statistics/fact_sheets/adult_data/cig_smoking/index.htm. Last accessed October 1, 2024.

4. American Lung Association. Tobacco Use among Children and Teens. Available at https://www.lung.org/quit-smoking/smoking-facts/tobacco-use-among-children. Last accessed October 1, 2024.

5. Centers for Disease Control and Prevention. Health Effects. Available at https://www.cdc.gov/tobacco/basic_information/health_effects/index.htm. Last accessed October 1, 2024.

6. Cockerham WC, Hamby BW, Oates GR. The social determinants of chronic disease. Am J Prev Med. 2017;41(suppl 1):S5-S12.

7. Centers for Disease Control and Prevention. People with Mental Health Conditions. Available at https://www.cdc.gov/tobacco/campaign/tips/groups/people-with-mental-health-conditions.html. Last accessed October 1, 2024.

8. U.S. Food and Drug Administration. Think E-cigs Can't Harm Teens' Health? Available at https://www.fda.gov/tobacco-products/public-health-education/think-e-cigs-cant-harm-teens-health. Last accessed October 1, 2024.

9. Balfour DJK, Benowitz NL, Colby SM, et al. Balancing consideration of the risks and benefits of e-cigarettes. Am J Public Health. 2021;111(9):1661-1672.

10. American Heart Association. Smokers, Especially Those Who Begin Young, Are Three Times More Likely to Die Prematurely. Available at https://newsroom.heart.org/news/smokers-especially-those-who-begin-young-are-three-times-more-likely-to-die-prematurely. Last accessed October 1, 2024.

11. Centers for Disease Control and Prevention. Cancer and Tobacco Use. Available at https://www.cdc.gov/vitalsigns/cancerandtobacco. Last accessed October 1, 2024.

12. Centers for Disease Control and Prevention. Health Effects of Cigarette Smoking Data. Available at https://www.cdc.gov/tobacco/data_statistics/fact_sheets/health_effects/effects_cig_smoking/index.htm. Last accessed October 1, 2024.

13. U.S. Food and Drug Administration. How Smoking Affects Heart Health. Available at https://www.fda.gov/tobacco-products/health-effects-tobacco-use/how-smoking-affects-heart-health. Last accessed October 1, 2024.

14. Centers for Disease Control and Prevention. Benefits of Quitting Smoking. Available at https://www.cdc.gov/tobacco/about/benefits-of-quitting.html. Last accessed October 1, 2024.

15. Höpner J, Junge U, Schmidt-Pokrzywniak A, Fischer C, Mikolajczyk R. Determinants of persistent smoking after acute myocardial infarction: an observational study. BMC Cardiovasc Disord. 2020;20(1):384.

16. Tiwari RK, Sharma V, Pandey RK, Shukla SS. Nicotine addiction: neurobiology and mechanism. J Pharmacopuncture. 2020;23(1):1-7.

17. Yang B, Owusu D, Popova L. Effects of a nicotine fact sheet on perceived risk of nicotine and e-cigarettes and intentions to seek information about and use e-cigarettes. Int J Environ Res Public Health. 2019;17(1):131.

18. Fiore MC, Jaén CR, Baker TB, et al. Treating Tobacco Use and Dependence: 2008 Update. Clinical Practice Guidelines. Washington, DC: U.S. Department of Health and Human Services, Public Health Service; 2008.

19. Truth Initiative. Quitting Tobacco: Facts and Stats. Available at https://truthinitiative.org/research-resources/quitting-smoking-vaping/quitting-tobacco-facts-and-stats. Last accessed October 1, 2024.

20. Lindson-Hawley N, Aveyard P, Hughes JR. Reduction versus abrupt cessation in smokers who want to quit. Cochrane Database Syst Rev. 2012;11:CD008033.

21. Lindson-Hawley N, Banting M, West R, Michie S, Shinkins B, Aveyard P. Gradual versus abrupt smoking cessation: a randomized, controlled noninferiority trial. Ann Intern Med. 2016;164(9):585-592.

22. DiPiro J, Yee G, Haines ST, Nolin TD, Ellingrod V, Posey LM. Pharmacotherapy: A Pathophysiologic Approach. 12th ed. New York, NY: McGraw-Hill; 2023.

23. Hartmann-Boyce J, Chepkin SC, Ye W, Bullen C, Lancaster T. Nicotine replacement therapy versus control for smoking cessation. Cochrane Database Syst Rev. 2018;5:CD000146.

24. Stead LF, Perera R, Bullen C, et al. Nicotine replacement therapy for smoking cessation. Cochrane Database Syst Rev. 2012;11: CD000146.

25. Hughes JR, Stead LF, Hartmann-Boyce J, Cahill K, Lancaster T. Antidepressants for smoking cessation. Cochrane Database Syst Rev. 2014;1:CD000031.

26. Anthenelli RM, Benowitz NL, West R, et al. Neuropsychiatric safety and efficacy of varenicline, bupropion, and nicotine patch in smokers with and without psychiatric disorders (EAGLES): a double-blind, randomised, placebo-controlled clinical trial. Lancet. 2016;387(10037):2507-2520.

27. Cahill K, Lindson-Hawley N, Thomas KH, Fanshawe TR, Lancaster T. Nicotine receptor partial agonists for smoking cessation. Cochrane Database Syst Rev. 2016;CD006103.

28. Chang PH, Chiang CH, Ho WC, Wu PZ, Tsai JS, Guo FR. Combination therapy of varenicline with nicotine replacement therapy is better than varenicline alone: a systematic review and meta-analysis of randomized controlled trials. BMC Public Health. 2015;15:689.

29. Park ER. Behavioral Approaches to Smoking Cessation. Available at https://www.uptodate.com/contents/behavioral-approaches-to-smoking-cessation. Last accessed October 1, 2026.

30. Anderson GD, Chan LN. Pharmacokinetic drug interactions with tobacco, cannabinoids and smoking cessation products. Clin Pharmacokinet. 2016;55(11):1353-1368.

31. Li H, Shi Q. Drugs and diseases interacting with cigarette smoking in US prescription drug labelling. Clin Pharmacokinet. 2015;54(5): 493-501.

32. Faber MS, Fuhr U. Time response of cytochrome P450 1A2 activity on cessation of heavy smoking. Clin Pharmacol Ther. 2004;76(2): 178-184.